proteomics


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

proteomics

[‚prōd·ē′äm·iks]
(cell and molecular biology)
The separation, identification, and characterization of the complete set of proteins present in the various cells of an organism.
References in periodicals archive ?
The Proteomics Congress has a strong emphasis on support and inspiration for the next generation of scientists, along with early-career researchers, a Young Researchers Forum, and activities to encourage interaction with peers and experts.
High cost of the medicines and devices and lack of professional researchers are acting as a barrier for the proteomics market.
MRM Proteomics, is recognized as a pioneer and leading company in the development of mass spec based methods for protein quantification using multiple reaction monitoring," said Steve Fischer, Agilent marketing manager, Metabolomics and Proteomics.
The book begins with a well-composed contemplation of the current and future value of proteomics to the clinical sciences by Marc Reymond, which includes a succinct discussion of the ethical implications of such research.
Our new partnership with Zymark confirms our commitment to employ the best technologies available in proteomics research and discoveries," added Loiret-Bernal.
Proteomics research at the NCT focuses largely on changes in an organism's proteome in response to an event such as exposure to an environmental toxicant, in order to advance understanding of how people might respond to chemical exposures in their environment.
Our ability to meet the goal of delivering protein candidates so quickly validates our vision of an industrial-scale proteomics approach," said Cedric Loiret-Bernal, MD, and CEO of GeneProt.
Nawin Mishra, a world-renowned speaker and leader in proteomics studies who has worked with the late Nobel Laureate E.
The activity-based strategy may mark a major improvement over the usual proteomics approaches, which are based on the relative abundance of a particular protein target.
This alliance brings two leaders in their respective fields together with a common purpose, to speed the development of new drugs for treating some of the major diseases plaguing our society today," said Frank Gleeson, president and chief executive officer of MDS Proteomics.
The application of proteomics in the clinical environment is limited due to a lack of knowledge regarding which proteins are most useful for analysis and how data are interpreted and represented.